Congrats to all readers. Medtronic has agreed to buy OSTE for $6.50 per share.

We first wrote about OSTE in January at $3.50 per share.

Disclosure: Affiliates of Envoy Global Research, and its principals, own shares in OSTE. All ideas, opinions, and/or forecasts, expressed or implied herein, are for informational purposes only and should not be construed as a recommendation to invest, trade, and/or speculate in the markets. Any investments, trades, and/or speculations made in light of the ideas, opinions, and/or forecasts, expressed or implied herein, are committed at your own risk, financial or otherwise.